Latest journalAll journals
EMJ Urology 10 [Supplement 2] 2022
As part of the 37th Annual European Association of Urology (EAU) Congress, this symposium presented key data from the CLEAR study: a Phase III randomised controlled trial evaluating lenvatinib plus pembrolizumab versus sunitinib in patients with advanced renal cell carcinoma (RCC) in the first-line (1L) setting.
Latest articlesAll articles
Newsletters & Alerts
Congress reviewsAll congress reviews
Review of the 37th Annual Meeting of the European Association of Urology (EAU) 2022
THE 37th Annual Meeting of the European Association of Urology (EAU) took place in Amsterdam, the Netherlands, and online between the 1st–4th July 2022. The opening ceremony began with a piano performance from the talented Wibi Soerjadi and a unique artistic display from a sand magician, who demonstrated his art by using sand alone.
Let’s Take a Look at the Very Best of EAU22: Great Topics, Great Research, and Great Teamwork
The European Association of Urology (EAU) delved into the very latest in urological science at the 37th Annual Congress, EAU22, on 1st–4th July in Amsterdam, the Netherlands. The four days were filled to the brim with 2,580 presentations by more than 900 speakers, and 56 courses organised by the European School of Urology (ESU).